Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Guerrot

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Frontiers in Molecular Biosciences|March 29, 2021
Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal SyndromeMouad Hamzaoui, Clothilde Roche, David Coquerel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 2025
SGLT2 inhibition for patients with ADPKD - closing the evidence gapRoman-Ulrich Müller, Dominique Guerrot, Michel Chonchol, et al.
Plos One|March 27, 2015
The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia / small lymphocytic lymphoma: a 25-year multicenter experienceAnne-Laure Poitou-Verkinder, Arnaud Francois, Fanny Drieux, et al.
Nephrologie & Therapeutique|February 8, 2021
[ESUR recommendations on the use of contrast media: Practice survey, review and commentary by CJN, FIRN and SFNDT]Louis de Laforcade, Mickaël Bobot, Marie-France Bellin, et al.
Kidney International Reports|May 5, 2018
Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous NephropathyLena Berchtold, Gilbert Zanetta, Karine Dahan, et al.
The American Journal of Pathology|June 7, 2011
Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathyDominique Guerrot, Monique Kerroch, Sandrine Placier, et al.
Plos One|March 10, 2012
Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathyDominique Guerrot, Jean-Claude Dussaule, Mouna Mael-Ainin, et al.
Diagnostic and Interventional Imaging|February 3, 2021
Kidney and contrast media: Common viewpoint of the French Nephrology societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelinesLouis de Laforcade, Mickaël Bobot, Marie-France Bellin, et al.
Journal of the American Society of Nephrology : JASN|November 6, 2012
Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptorHanna Debiec, Melanie Hanoy, Arnaud Francois, et al.
Clinical Pharmacokinetics|December 14, 2017
Population Pharmacokinetic-Pharmacodynamic Modeling of Ropivacaine in Spinal AnesthesiaZoubir Djerada, Catherine Feliu, Yoann Cazaubon, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Frontiers in Molecular Biosciences|March 29, 2021
Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal SyndromeMouad Hamzaoui, Clothilde Roche, David Coquerel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 2025
SGLT2 inhibition for patients with ADPKD - closing the evidence gapRoman-Ulrich Müller, Dominique Guerrot, Michel Chonchol, et al.
Plos One|March 27, 2015
The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia / small lymphocytic lymphoma: a 25-year multicenter experienceAnne-Laure Poitou-Verkinder, Arnaud Francois, Fanny Drieux, et al.
Nephrologie & Therapeutique|February 8, 2021
[ESUR recommendations on the use of contrast media: Practice survey, review and commentary by CJN, FIRN and SFNDT]Louis de Laforcade, Mickaël Bobot, Marie-France Bellin, et al.
Kidney International Reports|May 5, 2018
Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous NephropathyLena Berchtold, Gilbert Zanetta, Karine Dahan, et al.
The American Journal of Pathology|June 7, 2011
Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathyDominique Guerrot, Monique Kerroch, Sandrine Placier, et al.
Plos One|March 10, 2012
Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathyDominique Guerrot, Jean-Claude Dussaule, Mouna Mael-Ainin, et al.
Diagnostic and Interventional Imaging|February 3, 2021
Kidney and contrast media: Common viewpoint of the French Nephrology societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelinesLouis de Laforcade, Mickaël Bobot, Marie-France Bellin, et al.
Journal of the American Society of Nephrology : JASN|November 6, 2012
Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptorHanna Debiec, Melanie Hanoy, Arnaud Francois, et al.
Clinical Pharmacokinetics|December 14, 2017
Population Pharmacokinetic-Pharmacodynamic Modeling of Ropivacaine in Spinal AnesthesiaZoubir Djerada, Catherine Feliu, Yoann Cazaubon, et al.
Pageof 14